HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-benzylcinnamide

structure in first source

Also Known As:

PT-3 compound

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Cinnamates: 48
      - N-benzylcinnamide: 3

Experts

1.	Nobsathian, Saksit: 2 articles (09/2017 - 07/2015)
2.	Suwanna, Nirut: 2 articles (09/2017 - 07/2015)
3.	Thangnipon, Wipawan: 2 articles (09/2017 - 07/2015)
4.	Tuchinda, Patoomratana: 2 articles (09/2017 - 07/2015)
5.	Puangmalai, Nicha: 1 article (09/2017)
6.	Soi-Ampornkul, Rungtip: 1 article (09/2017)
7.	Jantrachotechatchawan, Chanati: 1 article (07/2015)
8.	Ngampramuan, Sukonthar: 1 article (07/2015)
9.	Chen, Lin: 1 article (05/2015)
10.	Luo, Puying: 1 article (05/2015)

Related Diseases

1.	Body Weight (Weight, Body) 07/01/2015 - "The protective effects and underlying mechanisms of N-benzylcinnamide (PT-3), purified from Piper submultinerve, on brains of 90-week-old Wistar rats were investigated following daily intraperitoneal injection with 1.5 mg of PT-3/kg of body weight for 15 days. "
2.	Neuroblastoma 09/01/2017 - "Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in human SH-SY5Y neuroblastoma cells."
3.	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/01/2015 - "N-Benzylcinnamide induces apoptosis in HPV16 and HPV18 cervical cancer cells via suppression of E6 and E7 protein expression."

Related Drugs and Biologics

1.	Cholinergic Agents (Cholinergics)
2.	Scopolamine (Hyoscine)
3.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Intraperitoneal Injections